Mizuho Securities USA LLC Raises Holdings in The Clorox Company (NYSE:CLX)

by · The Cerbat Gem

Mizuho Securities USA LLC raised its holdings in The Clorox Company (NYSE:CLX – Free Report) by 46,877.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,500,000 shares of the company’s stock after purchasing an additional 4,490,421 shares during the quarter. Clorox accounts for 1.9% of Mizuho Securities USA LLC’s holdings, making the stock its 14th largest holding. Mizuho Securities USA LLC owned 3.64% of Clorox worth $733,095,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CLX. Innealta Capital LLC purchased a new stake in Clorox in the second quarter valued at approximately $30,000. Trifecta Capital Advisors LLC boosted its position in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the period. First Foundation Advisors acquired a new stake in shares of Clorox in the first quarter valued at $31,000. Family Firm Inc. purchased a new position in Clorox in the second quarter valued at $31,000. Finally, Quarry LP grew its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $167.69 on Friday. The stock has a fifty day moving average price of $162.45 and a 200 day moving average price of $147.47. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.09. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a market cap of $20.76 billion, a PE ratio of 58.43, a P/E/G ratio of 3.06 and a beta of 0.41.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the business earned $0.49 EPS. Sell-side analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.91%. Clorox’s payout ratio is currently 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft lifted their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. BNP Paribas raised Clorox to a “strong sell” rating in a report on Friday, September 6th. Citigroup increased their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and a consensus price target of $155.00.

View Our Latest Analysis on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).